Literature DB >> 6546754

Complete primary structure for the zymogen of human complement factor B.

J E Mole, J K Anderson, E A Davison, D E Woods.   

Abstract

The entire amino acid sequence of complement factor B has been established combining both protein and DNA sequencing strategies. The zymogen consists of 739 amino acids, has four asparagine-linked carbohydrate sites, and has independently disulfide-bonded NH2- and COOH-terminal regions. The catalytic subunit, Bb, is a unique serine protease containing 259 amino acids that are not integral to any of the classical serine proteases. It is proposed that this region of the Bb fragment functions as a cofactor-binding domain for C3b. The Ba fragment was found to contain three regions of internal sequence homology which were unrelated to the "kringle" regions of prothrombin and plasminogen and which suggest an independent evolution for the B genome. Sequence alignment of the active site of B to the serine proteases was made using the three-dimensional structures of chymotrypsin and trypsin as molecular models. Three stretches within the hypothetical model for B contrast markedly with all known serine proteases in both amino acid sequences and predicted configuration. It is suggested that these "altered" regions contribute at least in part to the formation of the catalytic region of the C3 convertase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6546754

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  The insect immune protein scolexin is a novel serine proteinase homolog.

Authors:  C M Finnerty; P A Karplus; R R Granados
Journal:  Protein Sci       Date:  1999-01       Impact factor: 6.725

2.  Access to the complement factor B scissile bond is facilitated by association of factor B with C3b protein.

Authors:  Dennis E Hourcade; Lynne M Mitchell
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

3.  Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes.

Authors:  M D Moore; N R Cooper; B F Tack; G R Nemerow
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  Human prostate-specific antigen: structural and functional similarity with serine proteases.

Authors:  K W Watt; P J Lee; T M'Timkulu; W P Chan; R Loor
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

5.  Unusual ultrastructure of complement-component-C4b-binding protein of human complement by synchrotron X-ray scattering and hydrodynamic analysis.

Authors:  S J Perkins; L P Chung; K B Reid
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

6.  Identity of the putative serine-proteinase fold in proteins of the complement system with nine relevant crystal structures.

Authors:  S J Perkins; K F Smith
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

7.  A complement factor B mutation in a large kindred with atypical hemolytic uremic syndrome.

Authors:  Michinori Funato; Osamu Uemura; Katsumi Ushijima; Hidenori Ohnishi; Kenji Orii; Zenichiro Kato; Satoshi Yamakawa; Takuhito Nagai; Osamu Ohara; Hideo Kaneko; Naomi Kondo
Journal:  J Clin Immunol       Date:  2014-06-08       Impact factor: 8.317

8.  Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency.

Authors:  J E Volanakis; Z B Zhu; F M Schaffer; K J Macon; J Palermos; B O Barger; R Go; R D Campbell; H W Schroeder; M D Cooper
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

9.  The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Biochem J       Date:  1986-05-01       Impact factor: 3.857

10.  The gastrulation defective gene of Drosophila melanogaster is a member of the serine protease superfamily.

Authors:  K D Konrad; T J Goralski; A P Mahowald; J L Marsh
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.